GMPs Send Smaller Supplement Firms Into Contract Manufacturers’ Arms
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA enforcement of the good manufacturing practices final rule causes some in the supplement industry to question whether small and medium-sized firms can manufacture in-house successfully. Meanwhile, third-party manufacturers are realizing the benefits of a tighter regulatory environment.